🩺 HELLP Syndrome Recognition Simulator

Hemolysis — Fragmented Red Cells and Rising LDH

Microangiopathic hemolysis is the first HELLP hallmark.

• Present: Schistocytes (placeholder blood smear finding)
• >600 U/L: LDH (placeholder threshold)
• >1.2 mg/dL: Bilirubin (placeholder indirect fraction)
• Low: Haptoglobin (placeholder consumption marker)

Recognizing hemolysis on labs

Placeholder: hemolysis markers appear before overt symptoms.

Placeholder: LDH and smear review flag early hemolysis.

Elevated Liver Enzymes — AST/ALT Rise

Hepatocellular injury drives transaminases upward.

• >70 U/L: AST (placeholder elevated cutoff)
• >70 U/L: ALT (placeholder elevated cutoff)
• Possible: Liver tenderness (placeholder exam finding)
• Elevated: Capsule risk (placeholder hematoma risk)

Tracking enzyme trends

Placeholder: serial AST/ALT trends reveal worsening injury.

Placeholder: rapid enzyme rise warrants close monitoring.

Low Platelets — Thrombocytopenia

Platelet consumption marks disease severity.

• <100k/µL: Platelets (placeholder diagnostic cutoff)
• <50k/µL: Class 1 (placeholder severity class)
• Rising: Bleeding risk (placeholder clinical concern)
• Consider: Transfusion (placeholder threshold guidance)

Grading thrombocytopenia severity

Placeholder: platelet nadir correlates with complication risk.

Placeholder: falling platelets accelerate the care pathway.

Right Upper Quadrant Pain — Clinical Sign

RUQ or epigastric pain signals hepatic capsule strain.

• Common: RUQ pain (placeholder presenting symptom)
• Frequent: Nausea (placeholder associated symptom)
• Possible: Headache (placeholder overlapping sign)
• High: Exam urgency (placeholder triage priority)

Correlating symptoms with labs

Placeholder: pain plus abnormal labs raises suspicion sharply.

Placeholder: RUQ pain should prompt immediate lab review.

Urgent Delivery Decision — Trigger Point

Confirmed HELLP triggers time-critical delivery planning.

• Hours: Decision window (placeholder urgency scale)
• Case-based: Delivery mode (placeholder clinical judgment)
• Considered: Steroids (placeholder supportive measure)
• Continuous: Monitoring (placeholder maternal-fetal watch)

Triggering the delivery decision

Placeholder: combined criteria confirm need for urgent delivery.

Placeholder: delivery timing balances maternal and fetal risk.